Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.
A man wears the Dexcom G7 on his arm while taking photographs. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology ...
MiniMed (Nasdaq:MMED) announced today that it completed its previously announced initial public offering (IPO).
The MiniMed 780G system already has compatibility with Medtronic’s Guardian 4 and Simplera Sync sensors. Both offer up to seven days of wear. Now, with Instinct, users can more than double that sensor ...
CamDiab announced today that it is introducing CamAPS Liberty, a fully closed-loop feature for its CamAPS FX app.
Glooko announced today that it agreed to integrate its diabetes management platform with the Roche Accu-Chek SmartGuide CGM.
Trinity Biotech expects pivotal trial for CGM+ in 2026, platform moves toward regulatory submissions
The slim profile of the CGM+ sensor. [Image courtesy of Trinity Biotech] Trinity Biotech (Nasdaq:TRIB) today provided an update on the expected timeline for its CGM+ continuous glucose monitoring (CGM ...
Sequel Med Tech today announced the broad availability of its twiist automated insulin delivery system in the U.S.
BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it made its Mobi automated insulin delivery system available with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results